Knight Initiative for Brain Resilience

The first Monday of each month, the Knight Initiative for Brain Resilience will host monthly seminars to bring together awardees, affiliated professors and students for a series of 'lab meeting' styled talks. Two speakers will discuss their brain resilience research, experiences in the field, and answer questions about their work.

To support our researchers' participation in this open science ‘lab-meeting style’ exchange of ideas, these seminars are not streamed/recorded and are only open to members of the Stanford community. 

A team at Stanford, supported by the Knight Initiative for Brain Resilience, is using the biology of recovery to uncover why some aging brains withstand stress while others quietly unravel.

Four Stanford teams receive funding from the Knight Initiative for Brain Resilience to advance research on healthy brain aging and neurodegenerative diseases, including cellular resilience, a new theory of Parkinson’s Disease, and predicting individual aging trajectories.

Knight Initiative researchers discover a biomarker in spinal fluid that could help forecast Alzheimer’s progression and improve clinical trials.

Improving cells’ ability to sort and recycle components—including cholesterol—could lead to therapies for a wide range of neurodegenerative conditions.

This collaborative seminar is a joint effort of the Knight Initiative for Brain Resilience and the Paul F. Glenn Center for Biology of Aging Research.

To support our researchers' participation in this open science "lab-meeting style" exchange of ideas, these seminars are not streamed/recorded and are only open to members of the Stanford community. 

Tanya T. Paull, Burl G. and Lorene L. Rogers Chair in Human Health, Professor of Oncology

New Alzheimer's biomarkers focus on whether Alzheimer's has actually begun to affect a person's thinking and memory, rather than just amyloid levels.

A new analysis of a vaccination program in Wales by a Knight Initiative–supported team found that the shingles vaccine appeared to lower new dementia diagnoses by 20% — more than any other known intervention.

Knight Initiative–supported research by Pascal Geldsetzer and colleagues adds to evidence that preventing the viral infection can help stave off cognitive decline.